Updates in the Treatment of Melanoma: Metastatic Disease
The NCCN Guidelines are continuously updated to reflect the newest standards of care in oncology. With the increased pace of cancer research, the breadth of disease sites, the emergence of new diagnostic markers and imaging techniques, and the explosion of new treatment options, clinicians are challenged to keep up with these advances. The new treatment options include use of sentinel node biopsy for risk stratification, refined patient selection criteria for immunotherapy, use of combination therapies, and use of novel biologically targeted agents. Therefore, there is a great need for clinicians to maintain and continually add to their knowledge of scientific concepts and how those concepts can be applied in the everyday practice setting.
This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Evaluate the available clinical evidence for the treatment of metastatic melanoma
- Describe the appropriate treatment and management of melanoma along the continuum of care
Anthony J. Olszanski, MD
Fox Chase Cancer Center
- 0.25 Participation
- 0.18 Nurse
- 0.25 Pharmacist
- 0.25 Physician